【標靶】「DeepHRD」: 首個由OncoGaze™平台提出臨床可行生物標記，可識別「HRD」

 【標靶】「DeepHRD」: 第一個由「OncoGaze™」平台提出臨床可行的生物標記，可從切片中識別「同源重組修復缺失(HRD)」

 文章出處  

Businesswire 

 

 原文標題  

io9 Announces Publication in the Journal of Clinical Oncology Demonstrating Efficacy of OncoGaze™, its Next-Generation AI Platform Poised to Eliminate Delays and Inequities in Correct First-Line Precision Treatment Selection for Cancer Patients 

 

 Twitter  

https://x.com/aimedadviser/status/1819158707672174784 

 

 文章序號  

6029 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.